From a molecular pharmacy standpoint, Relafen 750 ( Naproxen Sodium ) presents a fascinating case study in medication action. Its mechanism of action primarily involves the blockade of cyclooxygenase ( COX mediators) enzymes, particularly the COX-2 isoform, leading to a reduction in the synthesis of PGE2 . This selective inhibition accounts for its